drugset / Trial / NCT02107014
Low Dose Naltrexone (LDN) Immune Monitoring
NaSingle-groupSingle-blindBasic science
Summary
We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 4.5 mg | Oral |